IDXX
IDEXX LABORATORIES INC /DEC5615-min delayed · EOD close535.38 +1.15% upas of 2026-09-04mkt cap $42.2B
In Vitro & In Vivo Diagnostic Substances · SIC 2835 · CIK 0000874716
Quality score
56/100
C
Growth61
Business quality95
Financial health34
Valuation34
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Highly uneven
Strongest on business quality (95), weakest on valuation (34). The composite is the mean of the sub-scores that could be computed. All inputs were available in the filings.
Revenue growth
16.8%
year over year
Earnings growth
28.4%
year over year
Gross margin